Lead integrated development and commercialization strategy for autoimmune CAR-T programs.
Establish lifecycle governance, decision frameworks, and cross-program coordination.
Partner with executive leadership to drive portfolio prioritization and investment decisions.
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for patients suffering from autoimmune diseases. The company is guided by core values including collaboration, clarity, and innovation, and is committed to transforming treatment for autoimmune disease.
Lead clinical development strategy and execution for CAR T-cell therapy trials in autoimmune diseases.
Oversee scientific content of protocols, regulatory documents, and clinical study reports.
Represent Clinical Development with cross-functional teams, KOLs, and external stakeholders.
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for autoimmune diseases. It fosters a culture of collaboration, innovation, and accountability with a focus on transforming treatment paradigms.
Serve as a field-based scientific expert engaging with healthcare professionals and key opinion leaders on autoimmune diseases and cell therapy.
Develop and execute territory-specific Medical Affairs and KOL engagement plans aligned with therapeutic area objectives.
Collaborate with Clinical Development and Clinical Operations to support company-sponsored clinical trials and scientific dialogue.
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for patients suffering from autoimmune diseases. The company is guided by core values such as 'Stay True to Why' and 'Boldly Innovative', and is committed to transforming treatment for autoimmune disease.
Develop and execute channel strategies for CAR T therapy delivery, balancing customer experience, compliance, and gross-to-net optimization.
Lead partnerships with third-party logistics and specialty pharmacies, and oversee state licensing and government pricing support.
Partner with cross-functional teams to design scalable channel infrastructure, assess economics, and mitigate risks.
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for autoimmune diseases. The company is guided by core values of collaboration, clarity, and innovation, and is committed to transforming treatment for autoimmune disease.
Drive strategic account leadership within key community oncology accounts, collaborating with cross-functional teams to develop and execute business strategies.
Manage contracting and access strategy, including negotiations and performance reviews to ensure provider-level access for CAR-T therapies.
Provide education and advocacy to P&T formulary decision makers, and engage with community-focused stakeholders to support Kite's strategic imperatives.
Kite is a biopharmaceutical company developing innovative cancer immunotherapies, specifically CAR-T cell therapies. As a subsidiary of Gilead Sciences, we are driven by the singular goal of curing cancer, fostering an inclusive and diverse culture.
Build and lead the US Field Medical Affairs organization, including hiring and managing a high-performing MSL team.
Implement field strategy in alignment with clinical development and launch plans, and oversee MSL training and analytics.
Collaborate internally and externally, track KPIs, and ensure compliance with regulations while engaging key opinion leaders.
The job posting states: 'Iovance Biotherapeutics aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapy for people with cancer. We are committed to continuous innovation in cell therapy, including gene-edited cell therapy, which may be a promising option for patients with cancer.'